Your browser doesn't support javascript.
loading
Prognostic Value of Serum Soluble PD-L1 in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab.
Wakita, Naoto; Hinata, Nobuyuki; Bando, Yukari; Hara, Takuto; Terakawa, Tomoaki; Furukawa, Junya; Nakano, Yuzo; Fujisawa, Masato.
Affiliation
  • Wakita N; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan; complus_duefl@yahoo.co.jp.
  • Hinata N; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Bando Y; Department of Urology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Hara T; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Terakawa T; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Furukawa J; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Nakano Y; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Fujisawa M; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
Anticancer Res ; 43(2): 841-847, 2023 Feb.
Article in En | MEDLINE | ID: mdl-36697079

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Anticancer Res Year: 2023 Document type: Article Country of publication: Greece

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Anticancer Res Year: 2023 Document type: Article Country of publication: Greece